Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol Editorial Material

Industry Collaboration International Collaboration

cited authors

  • Levy, Benjamin; Paz-Ares, Luis; Bennouna, Jaafar; Felip, Enriqueta; Rodriguez Abreu, Delvys; Isla, Dolores; Barlesi, Fabrice; Molinier, Olivier; Madelaine, Jeannick; Audigier-Valette, Clarisse; Kim, Sang-We; Kim, Hye Ryun; Ozguroglu, Mustafa; Erman, Mustafa; Badin, Firas Benyamine; Mekhail, Tarek M.; Scheff, Ronald; Chisamore, Michael J.; Sadrolhefazi, Behbood; Riess, Jonathan W.

authors

Publication Date

  • May 1, 2019

webpage

published in

category

keywords

  • ErbB family blocker
  • NSCLC
  • PD-1
  • Programmed cell death 1 receptor blocker
  • Tyrosine kinase inhibitor

start page

  • E407

end page

  • E412

volume

  • 20

issue

  • 3